NASDAQ:ACRX
Delisted
AcelRx Pharmaceuticals Stock News
$0.86
+0 (+0%)
At Close: Apr 08, 2024
NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX) and certain
NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX) and certain
New York, New York--(Newsfile Corp. - July 17, 2021) - WHY: New York, N.Y., July 17, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuti
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) between March 17, 2020 and Februa
AcelRx (ACRX) Inks Agreement With Aguettant for Dzuveo in Europe
03:24pm, Thursday, 15'th Jul 2021
AcelRx (ACRX) enters a licensing agreement for Dzuveo in Europe and an in-licensing agreement for two products in the United States.
ACRX Stock Increased 23.77%: Why It Happened
11:51pm, Wednesday, 14'th Jul 2021
The stock price of AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) increased by 23.77% today. This is why it happened.
5 Reddit Penny Stocks to Watch That Are Moving Right Now
03:58pm, Wednesday, 14'th Jul 2021
Are these Reddit penny stocks worth adding to your small-caps watchlist right now? The post 5 Reddit Penny Stocks to Watch That Are Moving Right Now appeared first on Penny Stocks to Buy, Picks, News
New York, New York--(Newsfile Corp. - July 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) betwe
AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe Products
09:28am, Wednesday, 14'th Jul 2021
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has agreed to provide a license to Laboratoire Aguettant to commercialize Dzuveo in Europe and give AcelRx two prefilled syringe product candidates for the
AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S.
08:30am, Wednesday, 14'th Jul 2021
HAYWARD, Calif., July 14, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative
New York, New York--(Newsfile Corp. - July 13, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: AC
NEW YORK, July 10, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX) and certain o
SHAREHOLDER ALERT: Robbins LLP Reminds Investors of a Class Action Against AcelRX Pharmaceuticals, Inc. (ACRX)
05:34pm, Thursday, 08'th Jul 2021
San Diego, California and Hayward, California--(Newsfile Corp. - July 8, 2021) - Shareholder rights law firm Robbins LLP reminds investors that a class action has been filed on behalf of all purchaser
New York, New York--(Newsfile Corp. - July 5, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX)
NEW YORK, July 4, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) between March 17, 202
